Literature DB >> 23096232

DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients.

Mustafa Gür1, Zafer Elbasan, Durmuş Yıldıray Şahin, Nermin Yıldız Koyunsever, Taner Seker, Betül Ozaltun, Murat Caylı, Abdurrahim Kocyigit.   

Abstract

DNA damage occurs more often in hypertensive patients than in non-hypertensive individuals. We sought to investigate lymphocyte DNA damage and total antioxidant status (TAS) levels in patients with dipper hypertension (DH) and non-dipper hypertension (NDH). Thirty-three patients with NDH (NDH group), 31 patients with DH (DH group) and 20 healthy volunteers (control group) were included in the study. Measurements from ambulatory blood pressure monitoring were obtained for all subjects. DNA damage was assessed in peripheral lymphocytes by comet assay, and plasma TAS levels were determined using an automated measurement method. The mean DNA damage value of the NDH group was higher than that of both the DH and control groups (P=0.002 and P<0.001, respectively). The mean DNA damage value of the DH group was higher than that of the control group (P<0.001). The mean TAS level of the NDH group was lower than that of both the DH and control groups (P=0.001 and P<0.001, respectively), and the mean TAS level of the DH group was lower than that of the control group (P<0.001). DNA damage was negatively associated with TAS level (r=-0.692, P<0.001) and positively associated with high sensitive c-reactive protein level (r=0.315, P=0.012). DNA damage increased in the NDH group compared with both the DH group and control group. This condition may be related to increased oxidative stress in the NDH group compared with the DH and control groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096232     DOI: 10.1038/hr.2012.156

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes.

Authors:  Rahul Kumar; Samantha Kohli; Zahara Ali; Kanika Duhan; Rekhbala Ram; Mohit Gupta; Sanjay Tyagi; Ghulam Mohammad; Ma Qadar Pasha
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 2.  Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life.

Authors:  Masashi Demura; Yosiki Demura; Yoshiyu Takeda; Kiyofumi Saijoh
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

3.  Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia.

Authors:  Giancarlo Zito; Renato Polimanti; Valentina Panetta; Mariacarla Ventriglia; Carlo Salustri; Maria Cristina Siotto; Filomena Moffa; Claudia Altamura; Fabrizio Vernieri; Domenico Lupoi; Emanuele Cassetta; Paolo M Rossini; Rosanna Squitti
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

4.  Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women.

Authors:  Rafael Bottaro Gelaleti; Débora Cristina Damasceno; Paula Helena Ortiz Lima; Daisy Maria Favero Salvadori; Iracema de Mattos Paranhos Calderon; José Carlos Peraçoli; Marilza Vieira Cunha Rudge
Journal:  Diabetol Metab Syndr       Date:  2015-01-15       Impact factor: 3.320

5.  Age at Natural Menopause and Blood Pressure Traits: Mendelian Randomization Study.

Authors:  Zayne M Roa-Díaz; Eralda Asllanaj; Hasnat A Amin; Lyda Z Rojas; Jana Nano; Mohammad Arfan Ikram; Fotios Drenos; Oscar H Franco; Raha Pazoki; Pedro Marques-Vidal; Trudy Voortman; Taulant Muka
Journal:  J Clin Med       Date:  2021-09-22       Impact factor: 4.241

6.  High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients.

Authors:  Murat Çaylı; Mustafa Gür; Zafer Elbasan; Taner Şeker; Caner Türkoğlu; Onur Kaypaklı; Durmuş Y Şahin; Hakan Uçar; Ali Kıvrak; Nermin Y Koyunsever; Ömer Sen
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-07       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.